Regulation of the pharmaceutical industry: promoting health or protecting wealth?

Government has long had conflicting aims with regard to regulating the pharmaceutical industry. An essay in the in the Journal of the Royal Society of Medicine asks how the National Health Service in the United Kingdom is balancing its public health and economic mandates.